Kobayashi Weisan is the flagship product of Kobayashi Pharmaceutical, and most of its revenue and profits are supported by this drug.
If he is really beaten by Jiu Xuan Wei San, then Kobayashi Pharmaceutical will definitely be seriously injured.
So, someone asked Masayoshi Kobayashi: "President, we can't just sit back and wait for death! Do you have any good ways to deal with it?"
Masayoshi Kobayashi said: "There are ways to deal with it, that is, we must increase investment in drug research and development, and quickly conduct a complete upgrade of our current products. If our Kobayashi Weisan can surpass Jiuxuan in terms of efficacy,
Weisan, the market is definitely still ours!"
The person in charge of R&D said: "President, if you want to increase investment in R&D, you will need a huge budget. The company was defrauded a lot of money some time ago. Can it still afford it now?"
Masayoshi Kobayashi said smoothly: "This is what I was about to tell you. Our current cash flow is not very good. The investment in the production base in Osaka cost a lot. Coupled with the previous unexpected losses, we are now able to use
The funds invested in research and development are already less than 50 million U.S. dollars, so my idea is to raise a fund as soon as possible, at least one billion U.S. dollars, to upgrade our drug R&D laboratory!"
As soon as everyone heard that they were going to raise funds, they all sat upright. Someone asked: "Mr. Chairman, do you have a suitable financing target now?"
Masayoshi Kobayashi nodded and said: "Previously, Chairman Jiro Kobayashi has been negotiating with Mr. Takehiko Ito, the patriarch of the Ito family, on financing matters. Everyone must know about this, right?"
Everyone nodded.
Kobayashi Jiro has always wanted to take Takehiko Ito's investment, and even wanted to become Takehiko Ito's son-in-law, otherwise he would not have spent money to sponsor the Sanda competition that Nanako Ito participated in. This has long been known to everyone in Kobayashi Pharmaceutical.
Everyone was even ready for the marriage between Kobayashi Pharmaceutical and the Ito family. Unfortunately, before the marriage was officially promoted, Jiro Kobayashi disappeared.
Everyone thought that the cooperation with the Ito family would also be terminated, but unexpectedly, Kobayashi Masayoshi would now start cooperation with the Ito family again.
As a result, everyone immediately became interested and asked excitedly: "Mr. Chairman, I wonder what kind of valuation the Ito family can give us?"
Masayoshi Kobayashi cleared his throat and said: "Mr. Takehiko Ito of the Ito family is willing to invest US$4.5 billion in Kobayashi Pharmaceutical at a valuation of US$15 billion. After the investment, it will account for 30% of the total shares of Kobayashi Pharmaceutical!
"
"Valuation of $15 billion?!"
Everyone couldn't help but start talking.
This was not the price that Jiro Kobayashi negotiated with Takehiko Ito at the beginning.
At that time, Jiro Kobayashi told everyone that the valuation would be at least US$20 billion.
Why has it suddenly dropped so much now?!
Someone raised a question: "Mr. Chairman, the Ito family's previous quotation was not so low. Why did it shrink so much all of a sudden?"
Someone else said: "Yeah! It has to be at least around 22 billion US dollars, right? A valuation of 15 billion US dollars is simply robbery..."
Xiaolin Zhengyi's expression was a little ugly, and he said: "You have to understand that we are facing internal and external troubles now. Not only is the president missing for no reason, but another Jiuxuanweisan has appeared in China. If we don't seize the time to raise funds at this time,
If Jiuxuan Weisan catches us off guard and our performance declines significantly, let alone a valuation of US$15 billion, even if it is US$10 billion, it is impossible to get it!"